LiDCO Group has appointed a master distributor in Latin America.
The patient monitoring devices supplier did not have representation in the region, which is around 10% of the global market for haemodynamic monitoring devices. The initial two-year agreement with Elysian Fields, which was formed by a former executive at Edwards Lifesciences who has experience of haemodynamic monitoring, covers the major markets in the region.
The latest version of LiDCO’s monitor will be registered in Brazil and Colombia by the end of this year.
There has been progress with the High Usage Programme (HUP) in the US. A public university medical centre in California has signed a five-year agreement for 15 monitors. LiDCO is replacing a rival manufacturer.
This takes annualised US recurring revenues to more than $1.5m.
LiDCO revenues are expected to fall from £8.3m to £7.3m in the year to January 2019. Next year revenues could recover to £8.5m. That should cut the loss from £2m to £800,000.
© 2020 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.